222 related articles for article (PubMed ID: 20479556)
21. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
Jadvar H; Henderson RW; Conti PS
J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
[TBL] [Abstract][Full Text] [Related]
22. Verification of musculoskeletal FDG-PET-CT findings performed for melanoma staging.
Mansour AA; Kelley MC; Hatmaker AR; Holt GE; Schwartz HS
Ann Surg Oncol; 2010 Apr; 17(4):1144-51. PubMed ID: 19967460
[TBL] [Abstract][Full Text] [Related]
23. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
24. Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas.
Wu HB; Wang QS; Wang MF; Li HS; Zhou WL; Ye XH; Wang QY
Nucl Med Commun; 2010 Mar; 31(3):195-200. PubMed ID: 20009963
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
Nakamoto Y; Osman M; Wahl RL
Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
[TBL] [Abstract][Full Text] [Related]
26. [Malignant tumor with false negative 18F-FDG PET image].
Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y
Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375
[TBL] [Abstract][Full Text] [Related]
28. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
29. 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.
van der Hoeven JJ; Krak NC; Hoekstra OS; Comans EF; Boom RP; van Geldere D; Meijer S; van der Wall E; Buter J; Pinedo HM; Teule GJ; Lammertsma AA
J Clin Oncol; 2004 Apr; 22(7):1253-9. PubMed ID: 15051773
[TBL] [Abstract][Full Text] [Related]
30. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
[TBL] [Abstract][Full Text] [Related]
31. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
[TBL] [Abstract][Full Text] [Related]
32. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 18 F-FAPI and 18 F-FDG PET/CT in a Patient With Fibrous Dysplasia.
Mu X; Li Z; Qin J; Wang Z; Fu W
Clin Nucl Med; 2024 Apr; 49(4):e182-e183. PubMed ID: 38377356
[TBL] [Abstract][Full Text] [Related]
34. Nodular fasciitis mimicking soft tissue metastasis on 18F-FDG PET/CT during surveillance.
Kim JY; Park J; Choi YY; Lee S; Paik SS
Clin Nucl Med; 2015 Feb; 40(2):172-4. PubMed ID: 25140556
[TBL] [Abstract][Full Text] [Related]
35. The appearance of Mazabraud's syndrome on 18F-FDG PET/CT.
Singnurkar A; Phancao JP; Chatha DS; Stern J
Skeletal Radiol; 2007 Nov; 36(11):1085-9. PubMed ID: 17589842
[TBL] [Abstract][Full Text] [Related]
36. Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CT.
Stegger L; Juergens KU; Kliesch S; Wormanns D; Weckesser M
Eur Radiol; 2007 Jul; 17(7):1784-6. PubMed ID: 17066288
[TBL] [Abstract][Full Text] [Related]
37. Cholesterol Granuloma: An Unusual and Benign Cause of Focal FDG Uptake in the Breast Detected on PET/CT.
Martineau P; Pelletier-Galarneau M; Leung E
Clin Nucl Med; 2015 Nov; 40(11):e511-3. PubMed ID: 26252338
[TBL] [Abstract][Full Text] [Related]
38. Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT.
von Falck C; Rosenthal H; Gratz KF; Galanski M
Clin Nucl Med; 2007 Aug; 32(8):640-2. PubMed ID: 17667441
[TBL] [Abstract][Full Text] [Related]
39. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
40. Mazabraud's Syndrome Mimicking Metastases on FDG PET/CT in a Patient With Colon Cancer.
Mahajan S; Goel R; Riedl C; Ulaner GA
Clin Nucl Med; 2018 Aug; 43(8):625-626. PubMed ID: 29863575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]